Inclusion of prescription drug reimportation provision in delaying action on homeland security appropriations

NewsGuard 100/100 Score

Provisions that would permit U.S. residents to purchase lower-cost prescription drugs from abroad have become a "major sticking point" to settling negotiations on the House and Senate fiscal year 2007 Homeland Security appropriations bills, CongressDaily reports (CongressDaily, 9/19).

The Senate in July voted 68-32 to approve an amendment that would prohibit seizures by U.S. Customs and Border Protection of prescription drugs purchased from Canadian pharmacies by U.S. residents. Sen. David Vitter (R-La.) proposed the amendment as part of the FY 2007 Homeland Security appropriations bill.

The House has approved two FY 2007 appropriations bills -- Homeland Security and Agriculture -- that include provisions to allow the purchase of prescription drugs from abroad.

The provision included in the House Homeland Security appropriations bill would allow the purchase of prescription drugs from any nation (Kaiser Daily Health Policy Report, 7/12).

Despite "widespread support among rank-and-file Republicans in both chambers," the measure has prompted opposition from the pharmaceutical industry as well as White House and GOP leaders, according to CongressDaily.

Senate Appropriations Chair Thad Cochran (R-Miss.) has offered compromise language that would block reimportation until FDA certifies that prescription drugs from other nations meet safety requirements.

However, some reimportation supporters have argued that Cochran's proposal would provide a means for the FDA chief to halt reimportation altogether by refusing to certify safety (CongressDaily, 9/19).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research identifies digital resources for reducing medication costs